Overexpression of MSK1 is associated with tumor aggressiveness and poor prognosis in colorectal cancer.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Digestive and Liver Disease

• Publication date

  2017-06-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.dld.2017.02.009PMID 28314603
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Fc-γ Receptor Polymorphisms, Cetuximab Therapy, and Survival in the NCIC CTG CO.17 Trial of Colorectal Cancer

  2016cited by this paper
• miR-203 enhances chemosensitivity to 5-fluorouracil by targeting thymidylate synthase in colorectal cancer.

  2015cited by this paper
• Molecular phenotypes of colorectal cancer and potential clinical applications

  2015cited by this paper
• KRAS as a predictor of poor prognosis and benefit from postoperative FOLFOX chemotherapy in patients with stage II and III colorectal cancer

  2015cited by this paper
• Mitogen- and stress-activated Kinase 1 mediates Epstein-Barr virus latent membrane protein 1-promoted cell transformation in nasopharyngeal carcinoma through its induction of Fra-1 and c-Jun genes

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Activation of mitogen- and stress-activated kinase 1 is required for proliferation of breast cancer cells in response to estrogens or progestins

  2014cited by this paper
• Kaempferol Targets RSK2 and MSK1 to Suppress UV Radiation-Induced Skin Cancer

  2014cited by this paper
• Phosphorylated p38, a negative prognostic biomarker, complements TNM staging prognostication in colorectal cancer

  2014cited by this paper
• p38α MAPK pathway: a key factor in colorectal cancer therapy and chemoresistance.

  2014cited by this paper
• Angiopoietin2 enhances doxorubin resistance in HepG2 cells by upregulating survivin and Ref-1 via MSK1 activation.

  2013cited by this paper
• Role of Glutathione in Cancer Progression and Chemoresistance

  2013cited by this paper
• Expression of the phosphorylated MEK5 protein is associated with TNM staging of colorectal cancer

  2012cited by this paper
• The Clinical Significance of MiR-148a as a Predictive Biomarker in Patients with Advanced Colorectal Cancer

  2012cited by this paper
• Regulation of cancer cell metabolism

  2011cited by this paper
• Inhibition of the p38 MAPK pathway sensitises human colon cancer cells to 5-fluorouracil treatment.

  2011cited by this paper
• Mice Lacking MSK1 and MSK2 Show Reduced Skin Tumor Development in a Two-Stage Chemical Carcinogenesis Model

  2011cited by this paper
• p38 mitogen-activated protein kinase-driven MAPKAPK2 regulates invasion of bladder cancer by modulation of MMP-2 and MMP-9 activity.

  2010cited by this paper
• MiR-148a Attenuates Paclitaxel Resistance of Hormone-refractory, Drug-resistant Prostate Cancer PC3 Cells by Regulating MSK1 Expression*

  2010cited by this paper
• Role of MSK1 in the Malignant Phenotype of Ras-transformed Mouse Fibroblasts*

  2010cited by this paper
• miR-192/miR-215 Influence 5-Fluorouracil Resistance through Cell Cycle-Mediated Mechanisms Complementary to Its Post-transcriptional Thymidilate Synthase Regulation

  2010cited by this paper
• Glutathione dysregulation and the etiology and progression of human diseases

  2009cited by this paper
• The versatile role of MSKs in transcriptional regulation.

  2009cited by this paper
• Wild-type KRAS is required for panitumumab efficacy in patients with metastatic colorectal cancer.

  2008cited by this paper
• Mitogen- and stress-activated kinase 1-mediated histone H3 phosphorylation is crucial for cell transformation.

  2008cited by this paper
• ERK and p38 MAPK-Activated Protein Kinases: a Family of Protein Kinases with Diverse Biological Functions

  2004cited by this paper
• Mitogen- and Stress-Activated Protein Kinase 1 Activity and Histone H3 Phosphorylation in Oncogene-Transformed Mouse Fibroblasts

  2004cited by this paper
• 5-Fluorouracil: mechanisms of action and clinical strategies

  2003cited by this paper
• Ser-10 phosphorylation of histone H3 and immediate early gene expression in oncogene-transformed mouse fibroblasts.

  2002cited by this paper
• Dihydropyrimidine dehydrogenase. Kinetic mechanism for reduction of uracil by NADPH.

  1993cited by this paper
• Clinical Pharmacology of 5-Fluorouracil

  1989cited by this paper
• Clinical pharmacokinetics of 5-fluorouracil and its metabolites in plasma, urine, and bile.

  1987cited by this paper

• MSK1 promotes colorectal cancer metastasis by increasing Snail protein stability through USP5-mediated Snail deubiquitination

  2025cites this paper
• Mitogen- and stress-activated protein kinase (MSK1/2) regulated gene expression in normal and disease states.

  2023cites this paper
• HOXC6 drives a therapeutically targetable pancreatic cancer growth and metastasis pathway by regulating MSK1 and PPP2R2B

  2023cites this paper
• The role of MAPK, notch and Wnt signaling pathways in papillary thyroid cancer: Evidence from a systematic review and meta-analyzing microarray datasets employing bioinformatics knowledge and literature

  2023cites this paper
• Discovery and Characterization of a Novel Series of Chloropyrimidines as Covalent Inhibitors of the Kinase MSK1

  2022cites this paper
• Highly Antiproliferative Latonduine and Indolo[2,3-c]quinoline Derivatives: Complex Formation with Copper(II) Markedly Changes the Kinase Inhibitory Profile

  2022cites this paper
• Discovering novel lung cancer associated antigens and the utilization of their autoantibodies in detection of lung cancer.

  2019cites this paper
• Mitogen and stress- activated protein kinase regulated gene expression in cancer cells.

  2019cites this paper
• MSK1 promotes cell proliferation and metastasis in uveal melanoma by phosphorylating CREB

  2019cites this paper
• Histone posttranslational modifications: Potential role in diagnosis, prognosis, and therapeutics of cancer

  2019cites this paper
• DNA hydroxymethylation of colorectal primary carcinoma and its association with survival

  2018cites this paper
• Efficacy of a Covalent ERK1/2 Inhibitor, CC-90003, in KRAS-Mutant Cancer Models Reveals Novel Mechanisms of Response and Resistance

  2018cites this paper
• High expression of mitogen-activated and stress-activated protein kinase 1 indicates poor prognosis in patients with glioma

  2018cites this paper